BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 21718593)

  • 1. Tumor shrinkage by cyclopamine tartrate through inhibiting hedgehog signaling.
    Fan Q; Gu D; He M; Liu H; Sheng T; Xie G; Li CX; Zhang X; Wainwright B; Garrossian A; Garrossian M; Gardner D; Xie J
    Chin J Cancer; 2011 Jul; 30(7):472-81. PubMed ID: 21718593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclopamine tartrate, an inhibitor of Hedgehog signaling, strongly interferes with mitochondrial function and suppresses aerobic respiration in lung cancer cells.
    Alam MM; Sohoni S; Kalainayakan SP; Garrossian M; Zhang L
    BMC Cancer; 2016 Feb; 16():150. PubMed ID: 26911235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclopamine tartrate, a modulator of hedgehog signaling and mitochondrial respiration, effectively arrests lung tumor growth and progression.
    Kalainayakan SP; Ghosh P; Dey S; Fitzgerald KE; Sohoni S; Konduri PC; Garrossian M; Liu L; Zhang L
    Sci Rep; 2019 Feb; 9(1):1405. PubMed ID: 30723259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the Smoothened inhibitor, IPI-926, on smoothened ciliary localization and Hedgehog pathway activity.
    Peluso MO; Campbell VT; Harari JA; Tibbitts TT; Proctor JL; Whitebread N; Conley JM; White KF; Kutok JL; Read MA; McGovern K; Faia KL
    PLoS One; 2014; 9(3):e90534. PubMed ID: 24608250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Requirement of TGFbeta signaling for SMO-mediated carcinogenesis.
    Fan Q; He M; Sheng T; Zhang X; Sinha M; Luxon B; Zhao X; Xie J
    J Biol Chem; 2010 Nov; 285(47):36570-6. PubMed ID: 20858897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of inhibition of hedgehog signaling on cell growth and migration of uveal melanoma cells.
    Duan F; Lin M; Li C; Ding X; Qian G; Zhang H; Ge S; Fan X; Li J
    Cancer Biol Ther; 2014 May; 15(5):544-59. PubMed ID: 24553082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hedgehog pathway inhibition in chondrosarcoma using the smoothened inhibitor IPI-926 directly inhibits sarcoma cell growth.
    Campbell VT; Nadesan P; Ali SA; Wang CY; Whetstone H; Poon R; Wei Q; Keilty J; Proctor J; Wang LW; Apte SS; McGovern K; Alman BA; Wunder JS
    Mol Cancer Ther; 2014 May; 13(5):1259-69. PubMed ID: 24634412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of smoothened signaling prevents ultraviolet B-induced basal cell carcinomas through regulation of Fas expression and apoptosis.
    Athar M; Li C; Tang X; Chi S; Zhang X; Kim AL; Tyring SK; Kopelovich L; Hebert J; Epstein EH; Bickers DR; Xie J
    Cancer Res; 2004 Oct; 64(20):7545-52. PubMed ID: 15492281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclopamine bioactivity by extraction method from Veratrum californicum.
    Turner MW; Cruz R; Mattos J; Baughman N; Elwell J; Fothergill J; Nielsen A; Brookhouse J; Bartlett A; Malek P; Pu X; King MD; McDougal OM
    Bioorg Med Chem; 2016 Aug; 24(16):3752-7. PubMed ID: 27338657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to inhibition of smoothened in diverse epithelial cancer cells that lack smoothened or patched 1 mutations.
    Galimberti F; Busch AM; Chinyengetere F; Ma T; Sekula D; Memoli VA; Dragnev KH; Liu F; Johnson KC; Guo Y; Freemantle SJ; Andrew AS; Greninger P; Robbins DJ; Settleman J; Benes C; Dmitrovsky E
    Int J Oncol; 2012 Nov; 41(5):1751-61. PubMed ID: 22923130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TAK-441, a novel investigational smoothened antagonist, delays castration-resistant progression in prostate cancer by disrupting paracrine hedgehog signaling.
    Ibuki N; Ghaffari M; Pandey M; Iu I; Fazli L; Kashiwagi M; Tojo H; Nakanishi O; Gleave ME; Cox ME
    Int J Cancer; 2013 Oct; 133(8):1955-66. PubMed ID: 23564295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological modulation of the Hedgehog pathway differentially affects dorsal/ventral patterning in mouse and human embryonic stem cell models of telencephalic development.
    Nat R; Salti A; Suciu L; Ström S; Dechant G
    Stem Cells Dev; 2012 May; 21(7):1016-46. PubMed ID: 22204396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hedgehog- and mTOR-targeted therapies for advanced basal cell carcinomas.
    Piérard-Franchimont C; Hermanns-Lê T; Paquet P; Herfs M; Delvenne P; Piérard GE
    Future Oncol; 2015 Nov; 11(22):2997-3002. PubMed ID: 26437034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibiting Hedgehog: An Update on Pharmacological Compounds and Targeting Strategies.
    Galperin I; Dempwolff L; Diederich WE; Lauth M
    J Med Chem; 2019 Sep; 62(18):8392-8411. PubMed ID: 30986059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. I only have eye for ewe: the discovery of cyclopamine and development of Hedgehog pathway-targeting drugs.
    Chen JK
    Nat Prod Rep; 2016 May; 33(5):595-601. PubMed ID: 26787175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the hedgehog signal transduction pathway at the level of GLI inhibits neuroblastoma cell growth in vitro and in vivo.
    Wickström M; Dyberg C; Shimokawa T; Milosevic J; Baryawno N; Fuskevåg OM; Larsson R; Kogner P; Zaphiropoulos PG; Johnsen JI
    Int J Cancer; 2013 Apr; 132(7):1516-24. PubMed ID: 22949014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hedgehog targeting by cyclopamine suppresses head and neck squamous cell carcinoma and enhances chemotherapeutic effects.
    Mozet C; Stoehr M; Dimitrova K; Dietz A; Wichmann G
    Anticancer Res; 2013 Jun; 33(6):2415-24. PubMed ID: 23749890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hedgehog signaling inhibition blocks growth of resistant tumors through effects on tumor microenvironment.
    Heller E; Hurchla MA; Xiang J; Su X; Chen S; Schneider J; Joeng KS; Vidal M; Goldberg L; Deng H; Hornick MC; Prior JL; Piwnica-Worms D; Long F; Cagan R; Weilbaecher KN
    Cancer Res; 2012 Feb; 72(4):897-907. PubMed ID: 22186138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hedgehog signaling overrides p53-mediated tumor suppression by activating Mdm2.
    Abe Y; Oda-Sato E; Tobiume K; Kawauchi K; Taya Y; Okamoto K; Oren M; Tanaka N
    Proc Natl Acad Sci U S A; 2008 Mar; 105(12):4838-43. PubMed ID: 18359851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smoothened as a new therapeutic target for human osteosarcoma.
    Hirotsu M; Setoguchi T; Sasaki H; Matsunoshita Y; Gao H; Nagao H; Kunigou O; Komiya S
    Mol Cancer; 2010 Jan; 9():5. PubMed ID: 20067614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.